Genospace Merges with Sarah Cannon to Provide Precision Medicine Cloud Platform

Precision medicine cloud software specialist, Genospace, is to be merged into Sarah Cannon, the global cancer institute of Hospital Corporation of America (HCA), and will operate as a Sarah Cannon subsidiary. The firms say the merger will enable the more effective use of molecular profiling data to match cancer patients to clinical trials. Terms of the deal were not disclosed, but the transaction is expected to close during Q1 2017.Genospace has developed a suite of software tools to enable the